Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation? Response

Affiliations

¹ Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: vivencio.barrios@gmail.com.
² Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain.

Comment

Vivencio Barrios et al. Rev Esp Cardiol (Engl Ed). 2014 May.

. 2014 May;67(5):418.

doi: 10.1016/j.rec.2014.01.009. Epub 2014 Apr 3.

¹ Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: vivencio.barrios@gmail.com.
² Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain.

No abstract available

Comment on

Does CHA₂DS₂-VASc score select patients who will benefit most from anticoagulation?
Pueo E, Campos B, Anguita M, Worner F. Pueo E, et al. Rev Esp Cardiol (Engl Ed). 2014 May;67(5):417-8. doi: 10.1016/j.rec.2014.01.005. Epub 2014 Apr 3. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774741 No abstract available.
Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care.
Barrios V, Escobar C, Calderón A, Rodríguez Roca GC, Llisterri JL, Polo García J. Barrios V, et al. Rev Esp Cardiol (Engl Ed). 2014 Feb;67(2):150-1. doi: 10.1016/j.rec.2013.07.009. Epub 2013 Nov 8. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24795129 No abstract available.